Patents by Inventor Peter A. Scott
Peter A. Scott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11786183Abstract: The present disclosure includes a medical monitoring hub as the center of monitoring for a monitored patient. The hub includes configurable medical ports and serial ports for communicating with other medical devices in the patient's proximity. Moreover, the hub communicates with a portable patient monitor. The monitor, when docked with the hub provides display graphics different from when undocked, the display graphics including anatomical information. The hub assembles the often vast amount of electronic medical data, associates it with the monitored patient, and in some embodiments, communicates the data to the patient's medical records.Type: GrantFiled: October 20, 2021Date of Patent: October 17, 2023Assignee: Masimo CorporationInventors: Massi Joe E. Kiani, Bilal Muhsin, Ammar Al-Ali, Anand Sampath, Peter Scott Housel, Eric Karl Kinast
-
Publication number: 20230310867Abstract: A method of controlling a neural stimulus, the neural stimulus being defined by at least one stimulus intensity parameter. The method comprises, generating a stimulus intensity parameter to control a stimulator that generates a stimulus current for application to a tissue, measuring a response of the tissue, evoked by the stimulus current, determining a response parameter indicative of the measured response, in response to the response parameter being less than a first threshold, setting the stimulus intensity parameter to a desired stimulus intensity level; and in response to the response parameter being greater than a second threshold, adjust the stimulus intensity parameter according to a feedback variable derived from the measured response.Type: ApplicationFiled: August 27, 2021Publication date: October 5, 2023Applicant: Saluda Medical Pty LtdInventors: Peter Scott Vallack Single, Joanne Carol Shiels Olecko, Robert Bruce Gorman, James Hamilton Wah
-
Publication number: 20230310870Abstract: An implantable pulse generator device (110) comprising a processor (117) configured to: receive, in a charging mode, electromagnetic radiation (106) from a charging device (102) wherein the electromagnetic radiation (106) transfers energy to the implantable device (110) to charge an energy storage device (104); measure, in a measurement mode, an electrical field parameter signal representing a neural response; and selectively transition between the charging mode and the measurement mode, such that the implantable device (110) does not receive electromagnetic radiation (106) from the charging device (102) during the measurement of the electrical field parameter signal.Type: ApplicationFiled: August 13, 2021Publication date: October 5, 2023Applicant: Saluda Medical Pty LtdInventors: Peter Scott Vallack Single, Dean Michael Karantonis
-
Patent number: 11776938Abstract: At least one array of LEDs (e.g., in a flip chip configuration) is supported by a substrate having a light extraction surface overlaid with at least one lumiphoric material. Light segregation elements registered with gaps between LEDs are configured to reduce interaction between emissions of different LEDs and/or lumiphoric material regions to reduce scattering and/or optical crosstalk, thereby preserving pixel-like resolution of the resulting emissions. Light segregation elements may be formed by mechanical sawing or etching to define grooves or recesses in a substrate, and filling the grooves or recesses with light-reflective or light-absorptive material. Light segregation elements external to a substrate may be defined by photolithographic patterning and etching of a sacrificial material, and/or by 3D printing.Type: GrantFiled: May 10, 2022Date of Patent: October 3, 2023Assignee: CREELED, INC.Inventors: John Edmond, Matthew Donofrio, Jesse Reiherzer, Peter Scott Andrews, Joseph G. Clark, Kevin Haberern
-
Publication number: 20230295145Abstract: The present disclosure relates to compounds and pharmaceutical compositions thereof, and methods of using the compounds and compositions in therapy, such as methods of treating cancer.Type: ApplicationFiled: May 24, 2023Publication date: September 21, 2023Inventors: Jakob Fuhrmann, Nicholas John Skelton, Peter Scott Dragovich
-
Publication number: 20230278989Abstract: The invention relates to processes for preparing isoindolin-1-one derivatives, and in particular processes for preparing (2S,3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[(1S)-1-hydroxy-1-(oxan-4-yl)propyl]-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]-2-methylpropanoic acid. The invention also relates to crystalline forms of the compound (2S,3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[(1S)-1-hydroxy-1-(oxan-4-yl)propyl]-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]-2-methylpropanoic acid and its salts.Type: ApplicationFiled: January 25, 2023Publication date: September 7, 2023Applicants: ASTEX THERAPEUTICS LIMITED, CANCER RESEARCH TECHNOLOGY LIMITEDInventors: Steven HOWARD, Benjamin David CONS, Jeffrey David ST. DENIS, Charlotte Mary GRIFFITHS-JONES, Steven Douglas HISCOCK, Rhian Sara HOLVEY, Alan Richard BURNS, David COUSIN, Hannah Louise DEXTER, Guillaume François PARRA, John Paul WATTS, Robert JEWELL, Jennifer Ann STOCKWELL, Kim Louise HIRST, Isabelle Anne LEMASSON, David John NASH, James Daniel OSBORNE, Jonas Calleja PRIEDE, Nicholas Paul RICHARDS, Aaron Michael DUMAS, Brian Christopher BISHOP, David PARRY-JONES, Jeremy Peter SCOTT, Meenakshi Sundaram SHANMUGHAM, Peter Richard MULLENS, David Charles LATHBURY, Darren James DIXON, Matthew James GAUNT
-
Patent number: 11750611Abstract: Methods to securely remediate a captive portal are provided. In these methods, a processor of a user device detects a connection, via a network, to a captive portal. Based on the detected connection to the captive portal, the processor launches a dedicated secure web browser, and selectively restricts access of the user device to the network in order to only allow, via the dedicated secure web browser, communications related to remediation with the captive portal.Type: GrantFiled: September 16, 2021Date of Patent: September 5, 2023Assignee: CISCO TECHNOLOGY, INC.Inventors: Vincent E. Parla, Valentiu Vlad Santau, Peter Scott Davis
-
Publication number: 20230241376Abstract: An implantable device for controllably stimulating a neural target. The device configured to electrically couple to a paddle electrode assembly, the paddle electrode assembly comprising a plurality of electrodes including a first group of one or more electrodes arranged on a ventral surface of a paddle body, and a second group of one or more electrodes arranged on a dorsal surface of the paddle body. The implantable device comprises stimulation circuitry, configured to provide stimulation energy to one or more electrodes of the paddle electrode assembly, measurement circuitry, configured to measure a response evoked from the neural target by the stimulation energy and sensed by one or more electrodes of the paddle electrode assembly, and an electrode selection module.Type: ApplicationFiled: February 1, 2023Publication date: August 3, 2023Applicant: Saluda Medical Pty LtdInventors: Peter Scott Vallack Single, John Louis Parker, Zubin Zarir Nanavati
-
Patent number: 11713840Abstract: A pipe fitting system, including a first pipe section with at least one male end, a second pipe section with at least one female end, and a connecting means for releasably connecting the pipe sections together such that the male end is at least partially received within the female end. The connecting means comprising releasably engageable first and second connectors associated with the first and second pipe sections respectively, wherein the first connector comprises at least one outwardly extending protrusion and wherein the second connector comprises corresponding recesses adapted to releasable receive the or each protrusion of the first connector. The pipe fitting system is suitable for applications such as end of line connections, repair/replacement of fixed existing pipes, and in enabling temporary removal of pipes for maintenance or access purposes.Type: GrantFiled: February 5, 2021Date of Patent: August 1, 2023Assignee: TWIST4LOCK PTY LTDInventors: Stuart Gibson, Peter Scott
-
Publication number: 20230233859Abstract: This disclosure relates to a device for applying a neural stimulus. A battery supplies electrical energy at a battery voltage and an electrode applies the electrical energy to neural tissue. A circuit measures the nervous response of the tissue and a voltage converter receives the electrical energy from the battery and controls a voltage applied to the electrode based on the measured nervous response of the tissue. This direct voltage control is energy efficient because losses across a typical current mirror are avoided. Further, the control based on the measured nervous response leads to automatic compensation of impedance variation due to in-growth or change in posture. As a result, the stimulation results in a desired neural response.Type: ApplicationFiled: April 4, 2023Publication date: July 27, 2023Applicant: Saluda Medical Pty LtdInventors: Peter Scott Vallack Single, James Hamilton Wah
-
Publication number: 20230200738Abstract: A device for recording evoked neural responses, comprising one or more stimulus electrodes and one or more sense electrodes. The device has a stimulus source for providing a stimulus to be delivered from the stimulus electrodes to a neural pathway in order to give rise to an evoked action potential on the neural pathway. The device has measurement circuitry for recording a neural compound action potential signal sensed at the sense electrodes. Crosstalk cancellation circuitry is configured to produce a stimulus crosstalk cancellation signal, and is configured to inject the stimulus crosstalk cancellation signal into the measurement circuitry. The stimulus crosstalk cancellation signal is configured to cancel a stimulus crosstalk voltage arising upon the one or more sense electrodes as a result of delivery of the stimulus.Type: ApplicationFiled: May 18, 2021Publication date: June 29, 2023Applicant: Saluda Medical Pty LtdInventors: Peter Scott Vallack Single, James Hamilton Wah
-
Patent number: 11672976Abstract: A lead (1) for an active implantable medical device comprising: an elongated, biocompatible, electrically non-conductive body (3); a plurality of electrically conductive filaments (5) inside the elongated body (3) to electrically connect electrical connectors (6) to corresponding electrodes (8); and at least one elongated decoy conductor (10) inside the elongated body (3) to electromagnetically couple with the plurality of electrically conductive filaments (5), wherein the at least one decoy conductor (10) has a higher electrical resistance than the plurality of electrical conductive filaments (5) to dissipate energy from currents induced by radio frequencies.Type: GrantFiled: October 8, 2020Date of Patent: June 13, 2023Assignee: Saluda Medical Pty LimitedInventor: Peter Scott Vallack Single
-
Patent number: 11664407Abstract: Pixelated-LED chips and related methods are disclosed. A pixelated-LED chip includes an active layer with independently electrically accessible active layer portions arranged on or over a light-transmissive substrate. The active layer portions are configured to illuminate different light-transmissive substrate portions to form pixels. Various enhancements may beneficially provide increased contrast (i.e., reduced cross-talk between pixels) and/or promote inter-pixel illumination homogeneity, without unduly restricting light utilization efficiency. In some aspects, an underfill material with improved surface coverage is provided between adjacent pixels of a pixelated-LED chip. The underfill material may be arranged to cover all lateral surfaces between the adjacent pixels. In some aspects, discontinuous substrate portions are formed before application of underfill materials. In some aspects, a wetting layer is provided to improve wicking or flow of underfill materials during various fabrication steps.Type: GrantFiled: January 19, 2021Date of Patent: May 30, 2023Assignee: CREELED, INC.Inventors: Peter Scott Andrews, Steven Wuester
-
Publication number: 20230078685Abstract: A method of controlling a neural stimulus by use of feedback. The neural stimulus is applied to a neural pathway in order to give rise to an evoked action potential on the neural pathway. The stimulus is defined by at least one stimulus parameter. A neural compound action potential response evoked by the stimulus is measured. From the measured evoked response a feedback variable is derived. A feedback loop is completed by using the feedback variable to control the at least one stimulus parameter value. The feedback loop adaptively compensates for changes in a gain of the feedback loop caused by electrode movement relative to the neural pathway.Type: ApplicationFiled: August 8, 2022Publication date: March 16, 2023Inventors: Peter Scott Vallack SINGLE, Dean Michael KARANTONIS
-
Patent number: 11603095Abstract: Techniques for controlling a vehicle based on a collision avoidance algorithm are discussed herein. The vehicle receives sensor data and can determine that the sensor data represents an object in an environment through which the vehicle is travelling. A computing device associated with the vehicle determines a collision probability between the vehicle and the object at predicted locations of the vehicle and object at a first time. Updated locations of the vehicle and object can be determined, and a second collision probability can be determined. The vehicle is controlled based at least in part on the collision probabilities.Type: GrantFiled: October 30, 2020Date of Patent: March 14, 2023Assignee: Zoox, Inc.Inventors: Peter Scott Schleede, Prateek Chandresh Shah
-
Patent number: 11603367Abstract: The invention relates to processes for preparing isoindolin-1-one derivatives, and in particular processes for preparing (2S,3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[(1S)-1-hydroxy-1-(oxan-4-yl)propyl]-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]-2-methylpropanoic acid. The invention also relates to crystalline forms of the compound (2S,3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[(1S)-1-hydroxy-1-(oxan-4-yl)propyl]-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]-2-methylpropanoic acid and its salts.Type: GrantFiled: March 28, 2018Date of Patent: March 14, 2023Assignees: ASTEX THERAPEUTICS LIMITED, CANCER RESEARCH TECHNOLOGY LIMITEDInventors: Steven Howard, Jeffrey David St. Denis, Charlotte Mary Griffiths-Jones, Steven Douglas Hiscock, Alan Richard Burns, David Cousin, Kim Louise Hirst, James Daniel Osborne, Jonas Calleja Priede, Aaron Michael Dumas, Brian Christopher Bishop, David Parry-Jones, Jeremy Peter Scott, Meenakshi Sundaram Shanmugham, Peter Richard Mullens, Darren James Dixon, Matthew James Gaunt
-
Publication number: 20230033122Abstract: A patient monitoring hub can communicate bidirectionally with external devices such as a board-in-cable or a dongle. Medical data can be communicated from the patient monitoring hub to the external devices to cause the external devices to initiate actions. For example, an external device can perform calculations based on data received from the patient monitoring hub, or take other actions (for example, creating a new patient profile, resetting baseline values for algorithms, calibrating algorithms, etc.). The external device can also communicate display characteristics associated with its data to the monitoring hub. The monitoring hub can calculate a set of options for combined layouts corresponding to different external devices or parameters. A display option may be selected for arranging a display screen estate on the monitoring hub.Type: ApplicationFiled: July 12, 2022Publication date: February 2, 2023Inventors: Bilal Muhsin, Massi Joe E. Kiani, Peter Scott Housel
-
Publication number: 20230021564Abstract: Measuring a neural response to a stimulus comprises applying an electrical stimulus, then imposing a delay during which the stimulus electrodes are open circuited. During the delay, a neural response signal present at sense electrodes is measured with a measurement amplifier, while ensuring that an impedance between the sense electrodes is sufficiently large that a voltage arising on the sense electrode tissue interface in response to the stimulus is constrained to a level which permits assessment of the neural response voltage seen at the sense electrode. For example the input impedance to the measurement amplifier (ZIN) can be, where ZC is the sense electrode(s) constant phase element impedance, Vs1?Vs2 is the differential voltage arising on the sense electrode tissue interface, and VE is the neural response voltage seen at the sense electrode.Type: ApplicationFiled: July 28, 2022Publication date: January 26, 2023Inventor: Peter Scott Vallack SINGLE
-
Patent number: 11561856Abstract: Various embodiments set forth techniques for erasure coding of replicated data blocks. The techniques include receiving, by a pre-designated node, data associated with an erasure coded strip from a first node; receiving, by the pre-designated node, a replica for a first data block; saving the replica in an erasure coded strip; and in response to a trigger condition, replacing, by the pre-designated node, the replica and at least one replica of a second data block with an error correction block.Type: GrantFiled: April 21, 2021Date of Patent: January 24, 2023Assignee: NUTANIX, INC.Inventors: Snehal Sharadchandra Kamble, Karan Gupta, Ajaykrishna Raghavan, Peter Scott Wyckoff
-
Publication number: 20230014405Abstract: Disclosed is a method of adapting the operation of an implantable device for delivering neurostimulation therapy to a patient. The method comprises: delivering the neurostimulation therapy to electrically excitable tissue of the patient according to at least one therapy parameter; measuring a physiological characteristic of the patient; adjusting the at least one therapy parameter according to a schedule of adjustment and the measured physiological characteristic; and repeating the delivering, measuring, and adjusting.Type: ApplicationFiled: July 15, 2022Publication date: January 19, 2023Applicant: Saluda Medical Pty LtdInventors: John Louis Parker, Peter Scott Vallack Single, Dean Michael Karantonis, Matthew Marlon Williams, Daniel John Parker, Samuel Nicholas Gilbert